News + Filings Transactions Holdings
All 13F 13D/G Other
|
Vivo Ventures VI, LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/11/2022 |
SC 13G/A
| Vivo Ventures VI, LLC reports a 5.7% stake in KalVista Pharmaceuticals, Inc. |
02/11/2022 |
SC 13D/A
| Vivo Ventures VI, LLC reports a 0% stake in Eiger BioPharmaceuticals, Inc. |
02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
08/06/2021 |
SC 13D/A
| Vivo Ventures VI, LLC reports a 4.9% stake in Eiger BioPharmaceuticals, Inc. |
02/12/2021 |
SC 13D/A
| Vivo Ventures VI, LLC reports a 5.5% stake in Eiger BioPharmaceuticals, Inc. |
02/12/2021 |
SC 13G/A
| Vivo Ventures VI, LLC reports a 5.9% stake in KalVista Pharmaceuticals, Inc. |
07/24/2020 |
SC 13G/A
| Vivo Ventures VI, LLC reports a 5.7% stake in VERONA PHARMA PLC |
02/13/2020 |
SC 13G/A
| Vivo Ventures VI, LLC reports a 5.7% stake in KalVista Pharmaceuticals, Inc. |
11/18/2019 |
SC 13D/A
| Vivo Ventures VI, LLC reports a 7.3% stake in Eiger BioPharmaceuticals, Inc. |
02/14/2019 |
SC 13D/A
| Vivo Ventures VI, LLC reports a 9.4% stake in Eiger BioPharmaceuticals, Inc. |
09/12/2018 |
SC 13G
| Vivo Ventures VI, LLC reports a 6% stake in KalVista Pharmaceuticals, Inc. |
11/01/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
05/05/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/13/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/01/2016 |
SC 13D
| Vivo Ventures VI, LLC reports a 23% stake in Eiger BioPharmaceuticals, Inc. |
04/19/2013 |
SC 13G
| Durata Therapeutics, Inc. reports a 5.4% stake in Durata Therapeutics, Inc. |
|
|